Imaging a genetically engineered oncolytic vaccinia virus (GLV-1h99) using a human norepinephrine transporter reporter gene

Clinical Cancer Research

Volumn 15, Issue 11, 2009, Pages 3791-3801

  Brader, Peter ^a,b   Kelly, Kaitlyn J ^a   Chen, Nanhai ^c,d   Yu, Yong A ^c,d   Zhang, Qian ^c,d   Zanzonico, Pat ^a   Burnazi, Eva M ^a   Ghani, Rashid E ^a   Serganova, Inna ^a   Hricak, Hedvig ^a   Szalay, Aladar A ^c,d   Fong, Yuman ^a   Blasberg, Ronald G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c GENELUX CORPORATION   (United States)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; (3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 124; NORADRENALIN TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CYTOTOXICITY; FEMALE; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT MESOTHELIOMA; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PANCREAS CANCER; PERSISTENT VIRUS INFECTION; PLEURA MESOTHELIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; TRANSGENE; VACCINIA VIRUS;

3-IODOBENZYLGUANIDINE; ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; GAMMA CAMERAS; GENETIC ENGINEERING; HUMANS; IMMUNOBLOTTING; IODINE RADIOISOTOPES; MALE; MESOTHELIOMA; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; ONCOLYTIC VIRUSES; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TRANSPLANTATION, HETEROLOGOUS; VACCINIA VIRUS;

EID: 66649123890     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-3236     Document Type: Article

References (31)

1. Soliman H, Agresta SV. Current issues in adolescent and young adult cancer survivorship. Cancer Control 2008;15:55-62.
2. Bianchi C, Bianchi T. Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health 2007;45:379-387 (Pubitemid 47217199)
3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
4. Adusumilli PS, Stiles BM, Chan MK, et al. Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses. J Gene Med 2006;8:603-615 (Pubitemid 43827253)
5. Woo Y, Adusumilli PS, Fong Y. Advances in oncolytic viral therapy. Curr Opin Investig Drugs 2006;7:549-559 (Pubitemid 43891034)
6. Yu W, Fang H. Clinical trials with oncolytic adenovirus in China. Curr Cancer Drug Targets 2007;7:141-148 (Pubitemid 46348628)
7. Adusumilli PS, Chan MK, Chun YS, et al. Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma. Cancer Biol Ther 2006;5:48-53. (Pubitemid 43234977)
8. McFadden G. Poxvirus tropism. Nat Rev Microbiol 2005;3:201-213 (Pubitemid 40298220)
9. Thorne SH, Hwang TH, Kirn DH. Vaccinia virus and oncolytic virotherapy of cancer. Curr Opin Mol Ther 2005;7:359-365 (Pubitemid 41103056)
10. Liu TC, Galanis E, Kirn D. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress. Nat Clin Pract Oncol 2007;4:101-117 (Pubitemid 46189539)
11. Liu TC, Kirn D. Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions. Cancer Res 2007;67:429-432 (Pubitemid 46192175)
12. Thorne SH, Bartlett DL, Kirn DH. The use of oncolytic vaccinia viruses in the treatment of cancer: a new role for an old ally? Curr Gene Ther 2005;5:429-443
13. Brader P, Stritzker J, Riedl CC, et al. Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging. Clin Cancer Res 2008.
14. Zhang Q, Yu YA, Wang E, et al. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus. Cancer Res 2007;67:10038-10046 (Pubitemid 47621255)
15. Che J, Doubrovin M, Serganova I, Ageyeva L, Zanzonico P, Blasberg R. hNIS-IRES-eGFP dual reporter gene imaging. Mol Imaging 2005;4:128-136 (Pubitemid 43143800)
16. Eersels J, Herscheid J. Manufacturing I-123- labelled radiopharmaceuticals: pitfalls and solutions. J Labelled Compds Radiopharm 2005;48:241-257 (Pubitemid 40547334)
17. 124I-MIBG. J Nucl Med 2007;48:827-836
18. Kelly K, Brader P, Rein A, et al. Attenuated multimutated herpes simplex virus-1 effectively treats prostate carcinomas with neural invasion while preserving nerve function. FASEB J 2008;22:1839-1848
19. Dock G. Influence of complicating diseases upon leukemia. AM J Med Sci 1904;127:563-592
20. Khuri FR, Nemunaitis J, Ganly I, et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med 2000;6:879-885 (Pubitemid 30644745)
21. Kelly KJ, Woo Y, Brader P, et al. Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma. Hum Gene Ther 2008;19:774-782
22. Sisson JC, Frager MS, Valk TW, et al. Scintigraphic localization of pheochromocytoma. N Engl J Med 1981;305:12-17 (Pubitemid 11071190)
23. 131I-metaiodobenzylguanidine. Ann Intern Med 1981;94:762-767
24. 111In-pentetreotide. Mol Ther 2004;10:553-561
25. Pacholczyk T, Blakely RD, Amara SG. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 1991;350:350-354 (Pubitemid 21912229)
26. Serganova I, Ponomarev V, Blasberg R. Human reporter genes: potential use in clinical studies. Nucl Med Biol 2007;34:791-807. (Pubitemid 47503822)
27. Mullen CA, Petropoulos D, Lowe RM. Treatment of microscopic pulmonary metastases with recombinant autologous tumor vaccine expressing interleukin 6 and Escherichia coli cytosine deaminase suicide genes. Cancer Res 1996;56:1361-1366 (Pubitemid 26080980)
28. Verzeletti S, Bonini C, Marktel S, et al. Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graftversus- leukemia: clinical follow-up and improved new vectors. Hum Gene Ther 1998;9:2243-2251 (Pubitemid 28498010)
29. McAuliffe PF, Jarnagin WR, Johnson P, Delman KA, Federoff H, Fong Y. Effec tive treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses. J Gastrointest Surg 2000;4:580-588
30. Adusumilli PS, Chan MK, Hezel M, et al. Radiation- induced cellular DNA damage repair response enhances viral gene therapy efficacy in the treatment of malignant pleural mesothelioma. Ann Surg Oncol 2007;14:258-269 (Pubitemid 44954297)
31. Eisenberg DP, Adusumilli PS, Hendershott KJ, et al. 5-Fluorouraciland gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in the treatment of pancreatic cancer. J Gastrointest Surg 2005;9:1068-77, discussion 77-79 (Pubitemid 41564102)